[3dem] Cryo-EM Processing in Industry - Webinar by Clovertex

[Mazdak Radjainia]

Hey everyone,

A quick reminder that our *Clovertex Webinar on Cryo-EM Processing in
Industry* is happening *tomorrow, March 13 at 11:00 AM EST (8:00 AM PST |
4:00 PM CET).*

We’re excited to have so many registrants and look forward to
discussing with our expert panelists: Katie Meze (Sanofi), Roberto Valverde
(Renasant Bio), and Simone Cavadini (FMI).

If there are specific topics or questions you’d like to see addressed, feel
free to email me in advance.

*Don’t forget to register if you haven’t already: *Webinar Registration Link
<https://urldefense.com/v3/__https://us02web.zoom.us/webinar/register/WN_r3SisAysR66Wh4JqbpOrTA*/registration__;Iw!!Mih3wA!C0eb5BuxrNDZvPPPhbQ0S93PVggs0P35ZJiPUKvJdggex4ps8NVagZlvrGM7JkbIezdvpJoSIZZUTK3blB8$ >

Looking forward to a great discussion!

Best,
Mazdak

On Mon, Mar 3, 2025 at 9:35 AM Mazdak Radjainia <mazdak at cryoduck.com> wrote:

> Dear 3DEM and CCP-EM Community,
>
> We are excited to invite you to the first webinar in the new Clovertex
> Webinar Series! This inaugural session will focus on *Cryo-EM Processing
> in Industry*, bringing together experts from pharma, biotech, and
> academia to discuss the unique aspects of processing cryo-EM data in
> industrial settings. The event is designed for scientists working in
> industry, those interested in transitioning to industry, and method
> developers aiming to bridge the gap between basic research and real-world
> applications. Webinar participants are encouraged to ask questions to our
> panelists, and we will do our best to address them during the webinar. If
> necessary, we will follow up offline to ensure all questions are answered.
>
>
> *Webinar Details*Title: Cryo-EM Processing in Industry
> Date & Time: *March 13 at 11:00 AM EST* (8:00 AM PST | 4:00 PM CET)
> Format: Roundtable discussion with interactive Q&A
> Registration: Webinar Registration Page
> <https://urldefense.com/v3/__https://us02web.zoom.us/webinar/register/WN_r3SisAysR66Wh4JqbpOrTA*/registration__;Iw!!Mih3wA!C0eb5BuxrNDZvPPPhbQ0S93PVggs0P35ZJiPUKvJdggex4ps8NVagZlvrGM7JkbIezdvpJoSIZZUTK3blB8$ >
> Panelists: Katie Meze (Sanofi), Roberto Valverde (Renasant Bio), Simone
> Cavadini (FMI)
>
>
> *About the Panelists*
> *Katarina (Katie) Meze, Ph.D. – Senior Scientist, Sanofi*
> Dr. Meze is a structural biologist specializing in small-molecule drug
> discovery at Sanofi. She applies cryo-EM and X-ray crystallography to study
> macromolecular mechanisms and support therapeutic development. She holds a
> Ph.D. from Cold Spring Harbor Laboratory and has extensive experience in
> structural biology, having trained at institutions such as the University
> of Michigan and the University of York. Dr. Meze is also a co-founder of
> WoINSPIREBio, a group dedicated to connecting women structural biologists
> in industry and academia.
>
> *Roberto Valverde, Ph.D. – Principal Scientist, Renasant Bio*
> Dr. Valverde earned his Ph.D. from Yale University in the laboratory of
> Professor Lynne Regan, Ph.D., where he focused on protein engineering.
> Following his graduate studies, he pursued postdoctoral research in the
> laboratory of Professor Stephen C. Harrison at Harvard Medical School,
> studying kinetochore assembly and regulation. After his postdoctoral
> training, he joined Relay Therapeutics as one of its earliest employees,
> where he established the company’s cryo-EM pipeline and contributed to
> structure-based drug discovery efforts. He was part of the early research
> team that developed RLY-4008, a selective FGFR2 inhibitor now in Phase 2
> clinical trials for FGFR2-altered cholangiocarcinoma, and RLY-2608, an
> allosteric mutant-selective PI3Kα inhibitor. Currently, Dr. Valverde is a
> Principal Scientist at Renasant Bio, where he leads structural biology and
> biophysics.
>
> *Simone Cavadini, Ph.D. – Platform Head, Structural Biology, Friedrich
> Miescher Institute for Biomedical Research (FMI), Basel*
> Dr. Cavadini leads the Structural Biology Platform at FMI Basel, where he
> and his team utilize advanced computational structural biology and cryo-EM
> to study chromatin structure, DNA repair mechanisms, and targeted protein
> degradation. With 15 years of cryo-EM experience, he has collaborated with
> Novartis since 2016 to expand a joint cryo-EM facility.
>
>
> *About Clovertex*Clovertex specializes in cryo-EM cloud infrastructure
> for biotech and pharma, delivering tailored, scalable, and compliant
> solutions that evolve with customer needs. As an AWS Life Sciences
> Competency Partner, Clovertex is recognized for its expertise in Research
> IT, particularly its impact on cryo-EM for drug discovery. Clovertex
> automates hardware, software, and data management within a customer’s own
> cloud account (e.g., AWS) while ensuring compliance with corporate IT
> policies. Continuously maintained and optimized, it’s the smart way to run
> cryo-EM on AWS and the cloud - so scientists can focus on science, not IT.
>
> We look forward to a lively discussion and hope to see you there:
>
> https://urldefense.com/v3/__https://us02web.zoom.us/webinar/register/WN_r3SisAysR66Wh4JqbpOrTA*/registration__;Iw!!Mih3wA!C0eb5BuxrNDZvPPPhbQ0S93PVggs0P35ZJiPUKvJdggex4ps8NVagZlvrGM7JkbIezdvpJoSIZZUTK3blB8$ 
>
> Best wishes,
>
> *Mazdak* | cryoDuck B.V.
> Home <https://urldefense.com/v3/__http://cryoduck.com__;!!Mih3wA!C0eb5BuxrNDZvPPPhbQ0S93PVggs0P35ZJiPUKvJdggex4ps8NVagZlvrGM7JkbIezdvpJoSIZZUkVENNLA$ > / Newsletter <https://urldefense.com/v3/__http://cryoduck.com/newsletter/__;!!Mih3wA!C0eb5BuxrNDZvPPPhbQ0S93PVggs0P35ZJiPUKvJdggex4ps8NVagZlvrGM7JkbIezdvpJoSIZZUruYCTkQ$ >
>  / Blog <https://urldefense.com/v3/__http://cryoduck.com/blog/__;!!Mih3wA!C0eb5BuxrNDZvPPPhbQ0S93PVggs0P35ZJiPUKvJdggex4ps8NVagZlvrGM7JkbIezdvpJoSIZZUs6mE32Y$ >
> +31610585016
> 5615EC 86 - Netherlands
>
>
>
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://mail.ncmir.ucsd.edu/pipermail/3dem/attachments/20250312/5e976e8f/attachment.html>